Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Current Deferred Revenue (2022 - 2025)

Stemtech's Current Deferred Revenue history spans 4 years, with the latest figure at $88393.0 for Q3 2025.

  • For Q3 2025, Current Deferred Revenue changed N/A year-over-year to $88393.0; the TTM value through Sep 2025 reached $88393.0, changed N/A, while the annual FY2024 figure was $1463.0, 97.39% down from the prior year.
  • Current Deferred Revenue for Q3 2025 was $88393.0 at Stemtech, down from $98249.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $98249.0 in Q2 2025 and bottomed at $1463.0 in Q4 2024.
  • The 4-year median for Current Deferred Revenue is $75907.0 (2023), against an average of $61533.5.
  • The largest YoY upside for Current Deferred Revenue was 75.49% in 2024 against a maximum downside of 97.39% in 2024.
  • A 4-year view of Current Deferred Revenue shows it stood at $39170.0 in 2022, then soared by 43.07% to $56039.0 in 2023, then tumbled by 97.39% to $1463.0 in 2024, then soared by 5941.9% to $88393.0 in 2025.
  • Per Business Quant, the three most recent readings for STEK's Current Deferred Revenue are $88393.0 (Q3 2025), $98249.0 (Q2 2025), and $6778.0 (Q1 2025).